CANCER-IMMUNOTHERAPY - CURRENT STATUS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS

被引：23

作者：

VANHAELSTPISANI, CM

PISANI, RJ

KOVACH, JS

机构：

[1] MAYO CLIN & MAYO FDN,DEPT ONCOL,ROCHESTER,MN 55905

[2] MAYO CLIN & MAYO FDN,DIV THORAC DIS & INTERNAL MED,ROCHESTER,MN 55905

来源：

MAYO CLINIC PROCEEDINGS | 1989年 / 64卷 / 04期

关键词：

D O I：

10.1016/S0025-6196(12)65736-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：451 / 465

页数：15

共 115 条

[61]

MIER JW, 1985, J BIOL RESP MODIF, V4, P35

[62]

MIER JW, 1987, CANCER B, V39, P19

[63]

MIESCHER S, 1986, J IMMUNOL, V136, P1899

[64] EFFECTIVENESS AND TOLERABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 DISSEMINATED MELANOMA [J].

MITCHELL, MS ;

KEMPF, RA ;

HAREL, W ;

SHAU, H ;

BOSWELL, WD ;

LIND, S ;

BRADLEY, EC .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :409-424

[65] ON LYMPHOKINES, CYTOKINES, AND BREAKTHROUGHS [J].

MOERTEL, CG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22) :3141-3141

[66] T-CELL NATURE OF SOME LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS - FREQUENCY-ANALYSIS OF LAK PRECURSORS WITHIN HUMAN T-CELL POPULATIONS AND CLONAL ANALYSIS OF LAK EFFECTOR-CELLS [J].

MORETTA, L ;

PENDE, D ;

COZZANI, R ;

MERLI, A ;

BAGNASCO, M ;

MINGARI, MC .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (12) :1623-1625

[67] SELECTIVE INVITRO GROWTH OF T-LYMPHOCYTES FROM NORMAL HUMAN BONE MARROWS [J].

MORGAN, DA ;

RUSCETTI, FW ;

GALLO, R .

SCIENCE, 1976, 193 (4257) :1007-1008

[68]

MULE JJ, 1985, J IMMUNOL, V135, P646

[69] ADOPTIVE IMMUNOTHERAPY OF ESTABLISHED PULMONARY METASTASES WITH LAK CELLS AND RECOMBINANT INTERLEUKIN-2 [J].

MULE, JJ ;

SHU, SY ;

SCHWARZ, SL ;

ROSENBERG, SA .

SCIENCE, 1984, 225 (4669) :1487-1489

[70]

MULE JJ, 1987, J IMMUNOL, V139, P285

← 2 3 4 5 6 7 8 9 10 11 →